Find an Eye MD near you!

Allergan announced it will develop and commercialize dry eye drug tavilermide through an exclusive licensing agreement with Mimetogen Pharmaceuticals.

Researchers have identified a steroid that has the potential to reverse cataracts by blocking α-crystallin aggregation.

Study finds that glaucoma patients are at higher risk for complications and show weaker visual improvement.

AGTC has filed a new drug application with the FDA to conduct a clinical trial of a gene therapy product to treat achromatopsia.

Case report brings to light a potentially under-diagnosed cause of ocular neuropathic pain – vitamin B12 deficiency.

Literature review finds no evidence to support routine use of NSAIDs after cataract surgery to prevent vision loss from CME.

Twitter

Diagnose This: Minimizing ocular movement during phacoemulsification

◦Attention colleagues! Please reach out to your member of Congress regarding the rising drug prices and lack of tra… https://t.co/XKu7NezQAj

Looks like a great weekend for the WVAEPS 2018 Scientific Conference at the Greenbrier!!! Hope you made your regis… https://t.co/CNa5LLXj1t

Suffering eye strain at work? Follow these tips from the American Academy of Ophthalmology to get some relief. https://t.co/tfR8etzzG9